Xin Lang Cai Jing·2025-10-16 02:38Group 1 - The core viewpoint of the news is that Spring Medical experienced a stock price increase of 5.04%, reaching 24.60 CNY per share, with a total market capitalization of 9.436 billion CNY [1] - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, primarily focusing on joint prosthetics and spinal implants [1] - The company's main revenue source is from medical device products, accounting for 99.89% of total revenue, with exports to various regions including Asia, South America, Africa, Oceania, and Europe [1] Group 2 - From the perspective of fund holdings, Guolian An Fund has a significant position in Spring Medical, with its Guolian An Stable Mixed A Fund holding 297,700 shares, representing 3.06% of the fund's net value [2] - The Guolian An Stable Mixed A Fund has achieved a year-to-date return of 27.33% and a one-year return of 28.43%, ranking 3332 out of 8161 and 3393 out of 8021 respectively in its category [2] - The fund manager, Shu Leyan, has been in charge for 2 years and 91 days, with the fund's total assets amounting to 333 million CNY [3]